Skip to content
The BIG Summit meets at the intersection of patient advocacy and venture investment
Patient advocacy organizations that leverage venture philanthropy—an approach to philanthropic giving that applies ...
Read More
BIO Coffee Chat: MFN proposals would harm innovation and access
Most Favored Nation (MFN) type drug pricing proposals that were proposed by the ...
Read More
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription ...
Read More
NIH Director says no studies link vaccines and autism in hearing on modernization
National Institutes of Health (NIH) Director Jay Bhattacharya acknowledged there are no studies ...
Read More
BIO lauds passage of PPRV reauthorization and legislation on PBM reform
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new ...
Read More
BIO tells Congress how to maintain US biotech leadership
Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate ...
Read More
EDITORS' CHOICE
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More
LATEST NEWS
BIO Events
The BIG Summit meets at the intersection of patient advocacy and venture investment
Patient advocacy organizations that leverage venture philanthropy—an approach to philanthropic giving that applies venture capital principles to achieve philanthropic goals—can provide vital funding sources for ...
Federal Policy
BIO Coffee Chat: MFN proposals would harm innovation and access
Most Favored Nation (MFN) type drug pricing proposals that were proposed by the Centers for Medicare & Medicaid Innovation (CMMI) in December 2025 would weaken ...
Editors' Choice
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Federal Policy
NIH Director says no studies link vaccines and autism in hearing on modernization
National Institutes of Health (NIH) Director Jay Bhattacharya acknowledged there are no studies indicating a link between any vaccine and autism as Senators pushed for ...
Editors' Choice
BIO lauds passage of PPRV reauthorization and legislation on PBM reform
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new treatments for children with rare diseases and measures targeting reform of pharmacy ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
BIO Investment Council will bring together VC and small biotechs to boost innovation
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation Organization (BIO) on Jan. 7 launched the ...
Read More
